Accendra Health, Inc.

Accendra Health, Inc.(ACH)股票分析

$0.313

-0.002 (-0.73%)收盤時

Loading chart…
最高
0.330
開盤
0.320
成交量加權均價
0.31
成交量
4.24M
市值
—
最低
0.273
成交金額
1.29M
企業價值/稅息折舊攤銷前利潤(TTM)
9.90

Accendra Health, Inc., formerly Owens & Minor, Inc., is a provider of products, technology, and services for health beyond the hospital for millions of people each year. The Company connects patients, providers, and insurers, delivering solutions for people living with chronic, complex health conditions. It provides delivery of products, including disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States. It offers a range of products and services for in-home care and delivery across diabetes treatment, home respiratory therapy (including home oxygen and non-invasive ventilation services), and obstructive sleep apnea treatment (including continuous positive airway pressure (CPAP) and bi-level positive airway pressure devices, and patient support services). The Company also provides clinical and administrative support services and related products and supplies.

AI 分析 of Accendra Health, Inc. (ACH)

賣出

Accendra Health Inc is not a good buy right now due to significant financial challenges and negative performance indicators. The current price is $0.428, with a staggering year-to-date change of -84.71%. The RSI is extremely low at 9.216, indicating oversold conditions, but this could suggest further declines rather than a rebound. The company has reported a net loss of $89.1 million in Q2 2026, and its gross margin has decreased to 38.22%, raising concerns about its profitability and operational efficiency. The main risk is the ongoing revenue decline, with a 10.1% drop in Q2 compared to the previous year, which could further impact investor confidence.

估值指標

Accendra Health, Inc.(ACH)目前預期本益比為 6.94,5 年平均預期本益比為 3.32。

預期本益比

嚴重高估
5 年均值 P/E
3.32
目前P/E
6.94
高估
4.44
低估
2.19

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
10.89
目前EV/EBITDA
9.90
高估
13.69
低估
8.09

預期股價營收比

嚴重低估
5 年均值 P/S
0.07
目前P/S
0.01
高估
0.09
低估
0.05

持有 ACH 的大戶

C

Coliseum Capital Management, LLC

+ 持有ACH

-27.57%

3個月報酬率

事件時間軸

2026-08-10 (ET)

17:00:00

Stocks Open Lower as Middle East Uncertainty Grows

12:30:00

Major Averages Mixed at Open Amid Middle East Uncertainty

07:00:00

Accendra Health CEO Edward Pesicka to Retire by 2026

07:00:00

Company Reports Q2 Revenue of $613.2M, Below Expectations

07:00:00

Accendra Health Adopts Section 382 Rights Agreement to Protect Shareholder Value

資訊

ACH 常見問題 —— 由 Alphio AI 解答

Accendra Health, Inc., formerly Owens & Minor, Inc., is a provider of products, technology, and services for health beyond the hospital for millions of people each year. The Company connects patients, providers, and insurers, delivering solutions for people living with chronic, complex health conditions. It provides delivery of products, including disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States. It offers a range of products and services for in-home care and delivery across diabetes treatment, home respiratory therapy (including home oxygen and non-invasive ventilation services), and obstructive sleep apnea treatment (including continuous positive airway pressure (CPAP) and bi-level positive airway pressure devices, and patient support services). The Company also provides clinical and administrative support services and related products and supplies. It operates in the Healthcare sector.

Accendra Health Inc is not a good buy right now due to significant financial challenges and negative performance indicators. The current price is $0.428, with a staggering year-to-date change of -84.71%. The RSI is extremely low at 9.216, indicating oversold conditions, but this could suggest further declines rather than a rebound. The company has reported a net loss of $89.1 million in Q2 2026, and its gross margin has decreased to 38.22%, raising concerns about its profitability and operational efficiency. The main risk is the ongoing revenue decline, with a 10.1% drop in Q2 compared to the previous year, which could further impact investor confidence.

kappashrike4 天前

I analyzed the key levels for $STRK. 0.05964 is the prior low reconstruction zone and the upper edge of the consolidation platform. After breaking above it, bearish pressure failed and bulls began testing upside space. On the signal side, the latest price is 0.11426, already far from the entry zone, with strong short-term absorption and no clear signs of distribution. Return is +909.01%. On the operational side, 0.11 is the psychological and short-term support conversion level; holding above it favors bulls, while a break below 0.10 calls for watching for a pullback. The 10x position has unrealized profit; I am taking partial profits in batches and using a trailing stop, not letting a winning trade turn into a gamble. $OG #EthereumRisesOver71%InQ3 $ACH

展開
SpotSquall4 天前

My current long-term altcoin portfolio: $ACH (Alchemy Pay) $LTC (Litecoin) $ETC (Ethereum Classic) $LDO (Lido) $FET (ASI) $PLUME (Plume) $SYRUP (Maple Finance) $CFG (Centrifuge) $TKO (Tokocrypto) $GEOD (Geodnet) My short-term trading portfolio: $BONK $BB $GUN $SOLV $SKL Adjustment: I sold LUMIA, LINEA, AXL, ALPINE, JUV, MITO, and RVN from both my trading portfolio and long-term portfolio, and replaced them with CFG.

展開
trendanchor2026/9/25

$ALGO $BCH $ACH A lot of crypto traders focus on finding the next big crypto opportunity, but having the right knowledge and guidance is what really helps you stay consistent. I have personally found Alyssa's approach to trading very different from the usual hype you see online. Following her signals made me my first 140,000, and it's only been a few months since I started following her approach. Her guidance has helped me become more confident with my decisions and less likely to trade emotionally whenever the market gets volatile. I'm still learning every day, but the difference in my mindset and overall approach to trading has been noticeable.

展開
rektcitadel462026/9/16

$TWT is at 0.4984. Short-term support is the lower Bollinger Band at 0.4958; a break below that would bring the 0.49 round number into focus. The Fear & Greed Index is 51, neutral. BTC has no clear direction, altcoin rotation is weak, and TWT is down 3.45% over 24h on only 0.4M in volume. MA5 has crossed below MA20, RSI at 32.9 is near oversold, but the MACD histogram has turned positive, and the funding rate of +0.0050% shows longs are still paying. The bias is bearish; on a rebound to 0.5000–0.5030, consider a short with TP1 at 0.4958 (lower Bollinger Band), TP2 at 0.4900 (previous low support), and SL at 0.5080 (above MA20). Also watch: $ACH and $PENDLE are relatively resilient. (Personal view only, for reference, not investment advice. Futures risk is extremely high, please strictly control position size.) [Data] Pair: TWTUSDT Direction: Short Entry: 0.5000-0.5030 TP1: 0.4958 TP2: 0.4900 SL: 0.5080

展開
註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易